Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 02, 2016 08:28 ET | Source: Catalyst Biosciences, Inc.

Catalyst Biosciences To Present at the Jefferies 2016 Complement Therapeutics Summit

SOUTH SAN FRANCISCO, Calif., May 02, 2016 (GLOBE NEWSWIRE) -- Catalyst Biosciences, Inc. (NASDAQ:CBIO), a leading biotechnology company focused on discovering and developing novel protease...
April 20, 2016 16:00 ET | Source: Catalyst Biosciences, Inc.

Catalyst Biosciences Announces New Employment Inducement Grants

SOUTH SAN FRANCISCO, Calif., April 20, 2016 (GLOBE NEWSWIRE) -- Catalyst Biosciences, Inc. (NASDAQ:CBIO), a clinical-stage biopharmaceutical company focused on creating and developing novel...
April 18, 2016 08:30 ET | Source: Catalyst Biosciences, Inc.

Catalyst Biosciences Announces Appointments of Chief Medical Officer and Vice President of Business Development

-- Dr. Howard Levy Appointed Chief Medical Officer; Deep Experience in Hematology Drug Development and Medicine -- -- Jeffrey Landau, Accomplished Corporate Development and Strategy Professional,...
February 01, 2016 08:00 ET | Source: Catalyst Biosciences, Inc.

Catalyst Biosciences to Present at 18th Annual BIO CEO & Investor Conference

SOUTH SAN FRANCISCO, Calif., Feb. 01, 2016 (GLOBE NEWSWIRE) -- Catalyst Biosciences, Inc. (NASDAQ:CBIO), a clinical-stage biopharmaceutical company focused on creating and developing novel...
September 28, 2015 08:00 ET | Source: Catalyst Biosciences, Inc.

Catalyst Biosciences Names Andrew Hetherington as Vice President of Manufacturing Operations

SOUTH SAN FRANCISCO, Calif., Sept. 28, 2015 (GLOBE NEWSWIRE) -- Catalyst Biosciences, Inc. (NASDAQ:CBIO), a clinical-stage biopharmaceutical company focused on creating and developing novel medicines...
September 02, 2015 16:01 ET | Source: Catalyst Biosciences, Inc.

Catalyst Biosciences, Inc. to Present at the Rodman & Renshaw 17th Annual Global Investment Conference

SOUTH SAN FRANCISCO, Calif., Sept. 2, 2015 (GLOBE NEWSWIRE) -- Catalyst Biosciences, Inc. (Nasdaq:CBIO), a clinical-stage biopharmaceutical company focused on creating and developing novel medicines...
August 20, 2015 16:05 ET | Source: Catalyst Biosciences, Inc.

Catalyst Biosciences Completes Merger With Targacept and Creates a Protease-Based Hemostasis and Anti-Complement Company

SOUTH SAN FRANCISCO, Calif., Aug. 20, 2015 (GLOBE NEWSWIRE) -- Catalyst Biosciences, Inc. (NASDAQ:CBIO), a clinical-stage biopharmaceutical company focused on creating and developing novel medicines...
June 24, 2015 09:30 ET | Source: Catalyst Biosciences, Inc.

Catalyst Biosciences Announces Positive Results From a Phase 1 Clinical Trial of Its Next Generation Coagulation Factor VIIa in Patients With Hemophilia A or B and Preclinical Results From Its Factor IX and Factor Xa Programs

- Phase 1 results support further development of next-generation and long-acting coagulation Factor VIIa, CB 813d/PF-05280602, in patients with hemophilia A or B - - Company made multiple...
June 16, 2015 09:00 ET | Source: Catalyst Biosciences, Inc.

Catalyst Biosciences Announces Multiple Data Presentations at the 2015 International Society on Thrombosis and Haemostatsis Meeting

SOUTH SAN FRANCISCO, Calif., June 16, 2015 (GLOBE NEWSWIRE) -- Catalyst Biosciences, Inc., a privately held biopharmaceutical company, today announced that data from three of its product candidates...
May 28, 2015 08:05 ET | Source: Catalyst Biosciences, Inc.

Catalyst Biosciences to Present at the Jefferies 2015 Global Healthcare Conference

SOUTH SAN FRANCISCO, Calif., May 28, 2015 (GLOBE NEWSWIRE) -- Catalyst Biosciences, Inc., a privately held biopharmaceutical company, today announced that Nassim Usman, Ph.D., President and CEO of...